This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medicines for Malaria Venture (Mmv). Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Sergio Wittlin
Introduction
Sergio Wittlin is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antimalarial compounds. His work focuses on creating effective treatments for malaria, schistosomiasis, and cancer.
Latest Patents
Wittlin holds a patent for "Dispiro 1,2,4-trioxolane antimalarials." This invention describes a means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane. The preferred compounds include a spiroadamantane group on one side of the trioxolane group and a spirocyclohexyl on the other side. Compared to artemisinin semisynthetic derivatives, these compounds are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites. Remarkably, they provide a single-dose cure for malaria and exhibit prophylactic activity against the disease. Additionally, these compounds are active against schistosomiasis and cancer. Wittlin's patent portfolio includes 1 patent.
Career Highlights
Throughout his career, Wittlin has worked with prominent organizations in the field of malaria research. He has been associated with Medicines for Malaria Venture, an organization dedicated to developing new treatments for malaria. His innovative approach and dedication to research have positioned him as a key figure in the fight against this global health issue.
Collaborations
Wittlin has collaborated with esteemed colleagues, including Jonathan L. Vennerstrom and Yuxiang Dong. Their combined expertise has contributed to the advancement of antimalarial research and the development of effective treatments.
Conclusion
Sergio Wittlin's contributions to medicinal chemistry and his innovative patent for antimalarial compounds highlight his commitment to addressing critical health challenges. His work continues to inspire advancements in the treatment of malaria, schistosomiasis, and cancer.